AROVELLA THERAPEUTICS LTD - FILES IND APPLICATION WITH U.S. FDA FOR FIRST-IN-HUMAN PHASE 1 TRIAL OF ALA-101

Reuters · 12/30/2025 01:18

Please log in to view news